Print Friendly
Resetting the Clock: Addressing Circadian Disorders
Phyllis Zee, MD
Associate Director, Center for Sleep & Circadian Biology, Professor, Northwestern University Institute for Neuroscience
This interview was conducted by Peter Cook on July 7, 2006.
Background
Dr. Phyllis Zee’s interest in circadian rhythms began in graduate school, after which she
completed a residency in neurology and fellowship in sleep medicine. Her career has combined clinical care, research,
and education in the area of circadian rhythms and sleep.
Circadian rhythms
A healthy person’s ability to sleep for a consolidated 7–8 hours a night and to maintain wakefulness during
the day is the product of the interaction between two regulatory processes: the build up of sleep drive (sleep homeostasis)
and circadian sleep propensity. “Circadian rhythms time physiological and behavioral rhythms, as well as promote
alertness during the day and sleep at night” Dr. Zee says. “All physiological, behavioral, and cellular activity
exhibit circadian rhythmicity.”
The epicenter of circadian rhythm governance in the brain is the suprachiasmatic nucleus (SCN),
which is located in the hypothalamus. The SCN is home to a set of rhythmic neurons. “They’re literally pace-makers and produce a near
24-hour endogenous rhythm,” Dr. Zee says. “What we know now is that these circadian rhythms are actually regulated
at a molecular level. Circadian rhythms are genetically regulated, self-sustaining, and the product of the interaction
of a number of circadian clock genes.”
The usual frequency of oscillation (period) of human circadian rhythms is slightly longer than 24
hours (24.1–24.2
hrs). However, the rhythm can be “entrained” to our standard 24-hour light/dark cycle. “If you lived
in a cave,” Dr. Zee says, “you wouldn’t operate on a 24-hour cycle. Every day you’d wake up and
go to bed a little later than the previous day. We call this free-running, or non-entrainment.” Light and melatonin
(produced by the pineal gland) are important time givers (or “zeitgebers”) that adjust the timing of the circadian
clock on a daily basis. Light is the strongest zeitgeber and it has been shown that it can regulate the speed at which
circadian genes are turned on or turned off.
Circadian Rhythm Sleep Disorders
Circadian rhythms regulate the timing of the sleep wake cycle and both sleep and wake propensity.
Although the exact mechanism by which this occurs is not yet clear, Dr. Zee explains that “there are neural pathways between the SCN
and other areas in the brain that regulate sleep and wakefulness.” In addition, the SCN regulates the timing of melatonin
secretion from the pineal gland. Once secreted, melatonin exerts its action on SCN neurons. “These SCN neurons contain
melatonin receptors, which when activated affect their timing as well as the level of electrical activity.” It has
been proposed that the ability of melatonin to attenuate the firing rate of SCN neurons is responsible for its sleep promoting
effects.
Unsurprisingly, when the regulation of circadian rhythms is altered, sleep disorders, called “circadian rhythm sleep
disorders” can result. One of the more common types are phase disorders such as delayed sleep phase and advanced
sleep phase. In these disorders, the major sleep period comes either hours later or earlier, respectively, than is generally
socially acceptable.
“Delayed sleep phase is more common in adolescents and young adults and may be comorbid with depression and other
mood disorders. Advanced sleep phase, is more often seen in older individuals, and it should be differentiated from early
insomnia associated with depression,” Dr. Zee says.
Another common circadian sleep disorder is shift-work sleep disorder. This occurs mostly in those
who work night shifts. Individuals with shift-work sleep disorder complain of difficulty sleeping during the day, and
difficulty staying awake during the night, particularly in the early morning hours. “There are many comorbidities attendant to shift-work
sleep disorder,” Dr. Zee says. “Obesity, GI disorders, cardiac disorders, substance abuse in effort to induce
wakefulness or sleepiness, and mood disorders are common.”
Patients with neurological disorders, such as Alzheimer’s disease, and older people in nursing homes, sometimes
fall prey to irregular sleep wake cycle disorder. They don’t have a consolidated bout of nightly sleep, and when
they do sleep, it’s in short, irregular bursts. There is data to suggest that in Alzheimer’s Disease, this
condition may at least in part due to deterioration of the SCN.
“Due to the lack of light perception, non-entrainment is mostly seen in blind people,” Dr. Zee says. “Patients
will complain of insomnia, excessive sleepiness, or both, depending on the time of the month. Because their sleep and wake
times are delaying every day, alignment with the 24 hour external day is also changing.” Non-entrainment is rare
in sighted individuals who may have alterations in their response to circadian synchronizing agents, or alternatively are
not exposed to bright light or structured social and physical activities.
The Cause
Although the exact underlying mechanisms responsible for many of the circadian rhythm sleep disorders are not well understood,
the evidence suggests that a combination of endogenous and exogenous factors are involved. For example, while the degradation
of neurons in the SCN may in part explain irregular sleep disorder, the lack of structured activities and bright light
exposure can also promote irregular cycles in the elderly with dementia.
“Several possibilities may also be involved in the development of delayed sleep phase,” says Dr. Zee. “An
unusually long circadian period, decreased sensitivity to entraining agents, or lack of light exposure can all contribute
to the delayed phase.”
Certain behaviors can perpetuate delayed and advanced sleep phase. Those with the former don’t
get the light they need in the morning, and those with the latter get too much light in the morning. Both conditions
appear to have a genetic basis. Delayed and advanced sleep phase can run in families. Recently, mutations in circadian
clock genes have been reported in families with advanced sleep phase, and scientists are looking for more genes involved
in both disorders.
Treatment
“For both delayed and advanced sleep phase light therapy is the first-line treatment,” Dr. Zee says. “Because
light in the morning usually advances the timing of circadian rhythms, and light in the evening delays circadian rhythms,
we can use timed light exposure to realign circadian rhythms.”
Patients with delayed sleep need to get more light in the early morning and less in the evening,
and vice versa for advanced phase patients. Melatonin has been shown to be useful for the treatment of delayed sleep
phase. However, most studies of melatonin for the treatment of sleep phase disorders have been smal, and its use is not
currently approved by the FDA for these indications. Light therapy during the night has been shown to help re-align circadian
rhythms and increase alertness in night shift-workers. Studies have shown that melatonin can help night shift workers
sleep during the day, but does not improve performance or alertness during night. Caffeine and scheduled naps can also
help improve alertness during the night. More recently, modafinil, a wake promoting agent, was approved by the FDA for
the excessive sleepiness that most of these patients experience during the night and early morning. For treating irregular
sleep disorder, light therapy is, again, very useful. “When the patients are older, or in a nursing home,” Dr. Zee says, “structured
physical and social activities during the day, keeping them engaged, has been shown to be very helpful.”
Conclusion
“This is an exciting time to be studying circadian rhythms,” Dr. Zee says. “We’re learning more
about the genetics and pathophysiology of sleep and other circadian disorders, though we’ve got a ways to go yet.
Of particular interest, it turns out that the genes which regulate circadian rhythms aren’t just in the SCN or the
CNS—they’re in cells of other tissues and organs. Thus, biological timing is likely to have important implications
for conditions ranging from sleep and mood disorders to respiratory, metabolic and cardiovascular disorders. The future
of this field of study lies in integrating an understanding of biological timing with psychiatric and medical disorders
beyond sleep.”
Disclosure: Dr. Zee has received financial support from Boehringer Ingelheim, the NIH, Schwarz
Bioscience, and Takeda; has been on the speaker’s bureau for sanofia aventis, Sepracor, and Takeda; and has been
a consultant to Boehringer Ingelheim, GlaxoSmithKline, Neurocrine, Pfizer, sanofi aventis, Sepracor, and Takeda.